GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRbeta proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.GAC0003A4 has been used in the study of advanced pancreatic cancers and other recalcitrant malignancies.
Molekulargewicht:
340.42
Reinheit:
98.41%
CAS Nummer:
[929492-71-7]
Formel:
C20H24N2O3
Target-Kategorie:
Liver X Receptor
T68316
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten